Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0159-2027

MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP Recall

MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP

FDA recall Class II

Ongoing

FDA lists this Class II recall for MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0159-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 17, 2026
FDA report date
Oct 21, 2026
Quantity in commerce
1366
Distribution
See key details
FDA cause
Process change control

What is being recalled?

MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SP

Affected model & UDI checker

Search the exact identifiers published for Z-0159-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
OPRO-101MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, Sample Pack, REF: OPRO-SPCheck source noticeNot specified
FDA code information

REF/UDI-DI/Lot(Expiration): OPRO-101/00884883005327/OPRO29061A(2029-06-30); OPRO-SP/00884883005358/OPRO2906SA(2029-06-30)

View the original FDA recall notice

Why was this product recalled?

Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient PTH results.

What actions did Microgenics Corporation take?

On 8/17/2026, recall notices were emailed to customers asking them to do the following: 1) If the variability of the material (PTH Analyte) exceeds your laboratory's specification, dispose of the material. of the material in accordance with local, regional, and national regulations. 2) Contact TechService.mgc@thermofisher.com for any additional support. 3) Customers using the affected product can continue to use the product as long as it meets their laboratory's specification and continue monitoring performance of PTH analyte. 4) This recall notice needs to be passed to anyone within your organization or any organization where the potentially affected lot have been transferred. 5) Retain a copy of this letter for your laboratory records. 6) Complete and return the Recall Response Form via email to MGCFSCA@thermofisher.com In addition, distributors were asked to do the following: - Please notify your customers of this Recall Notice using this recall notice and request they return a response to your contact information. - Firm is providing a customer response form template as a word document. Please place this letter on to your own letterhead and collect responses from your customers on that customer response form. Please note, customers should provide their response directly to your contact information. If you have any additional questions regarding this Recall Notice, contact the firm at 1-800-232-3342 (USA and Canada only) or 510-979-5000 (International), option 2, then option 3 or by email: TechService.mgc@thermofisher.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology